2018-2023 Global Overactive Bladder Treatment Consumption Market Report

August 2018 | 135 pages | ID: 2EC81619B21EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Overactive Bladder Treatment market for 2018-2023.
Overactive bladder (OAB) is a bladder disorder that results in an abnormal urge to urinate, urinary frequency, and nocturia (voiding at night). Some patients may also experience urinary incontinence (involuntary loss of bladder control).
North America is the largest consumption market of Overactive Bladder Treatment with prevalence as high as 11% and high medical level. In 2016, North America accounts for 49.59%.
Followed North America, Europe is the second largest consumption market with share of 27.84%. Besides, Japan is also an important market with market share over 17%. China and other Asian countries is the emerging market with the fastest growth rate, though there is no large manufacturer of Overactive Bladder Treatment drugs.
The Overactive Bladder Treatment market can be segmented as Anticholinergics, Mirabegron, Botox and Other Drugs. Among them, Anticholinergics account for the largest market share while it is in a decreasing trend. The growth rate of Mirabegron and Botox is fast.

Over the next five years, LPI(LP Information) projects that Overactive Bladder Treatment will register a 5.4% CAGR in terms of revenue, reach US$ 6460 million by 2023, from US$ 4710 million in 2017.

This report presents a comprehensive overview, market shares, and growth opportunities of Overactive Bladder Treatment market by product type, application, key manufacturers and key regions.

To calculate the market size, LP Information considers value and volume generated from the sales of the following segments:

Segmentation by product type:

• Anticholinergics
• Mirabegron
• Botox

Segmentation by application:

• Idiopathic Overactive Bladder
• Neurogenic Overactive Bladder

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Spain
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:

• Astellas Pharma
• Allergan
• Pfizer
• Teva (Activas)
• Johnson & Johnson

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

RESEARCH OBJECTIVES

• To study and analyze the global Overactive Bladder Treatment consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
• To understand the structure of Overactive Bladder Treatment market by identifying its various subsegments.
• Focuses on the key global Overactive Bladder Treatment manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
• To analyze the Overactive Bladder Treatment with respect to individual growth trends, future prospects, and their contribution to the total market.
• To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
• To project the consumption of Overactive Bladder Treatment submarkets, with respect to key regions (along with their respective key countries).
• To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
• To strategically profile the key players and comprehensively analyze their growth strategies.

Contents

2018-2023 GLOBAL OVERACTIVE BLADDER TREATMENT CONSUMPTION MARKET REPORT

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Overactive Bladder Treatment Consumption 2013-2023
  2.1.2 Overactive Bladder Treatment Consumption CAGR by Region
2.2 Overactive Bladder Treatment Segment by Type
  2.2.1 Anticholinergics
  2.2.2 Mirabegron
  2.2.3 Botox
2.3 Overactive Bladder Treatment Consumption by Type
  2.3.1 Global Overactive Bladder Treatment Consumption Market Share by Type (2013-2018)
  2.3.2 Global Overactive Bladder Treatment Revenue and Market Share by Type (2013-2018)
  2.3.3 Global Overactive Bladder Treatment Sale Price by Type (2013-2018)
2.4 Overactive Bladder Treatment Segment by Application
  2.4.1 Idiopathic Overactive Bladder
  2.4.2 Neurogenic Overactive Bladder
2.5 Overactive Bladder Treatment Consumption by Application
  2.5.1 Global Overactive Bladder Treatment Consumption Market Share by Application (2013-2018)
  2.5.2 Global Overactive Bladder Treatment Value and Market Share by Application (2013-2018)
  2.5.3 Global Overactive Bladder Treatment Sale Price by Application (2013-2018)

3 GLOBAL OVERACTIVE BLADDER TREATMENT BY PLAYERS

3.1 Global Overactive Bladder Treatment Sales Market Share by Players
  3.1.1 Global Overactive Bladder Treatment Sales by Players (2016-2018)
  3.1.2 Global Overactive Bladder Treatment Sales Market Share by Players (2016-2018)
3.2 Global Overactive Bladder Treatment Revenue Market Share by Players
  3.2.1 Global Overactive Bladder Treatment Revenue by Players (2016-2018)
  3.2.2 Global Overactive Bladder Treatment Revenue Market Share by Players (2016-2018)
3.3 Global Overactive Bladder Treatment Sale Price by Players
3.4 Global Overactive Bladder Treatment Manufacturing Base Distribution, Sales Area, Product Types by Players
  3.4.1 Global Overactive Bladder Treatment Manufacturing Base Distribution and Sales Area by Players
  3.4.2 Players Overactive Bladder Treatment Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 OVERACTIVE BLADDER TREATMENT BY REGIONS

4.1 Overactive Bladder Treatment by Regions
  4.1.1 Global Overactive Bladder Treatment Consumption by Regions
  4.1.2 Global Overactive Bladder Treatment Value by Regions
4.2 Americas Overactive Bladder Treatment Consumption Growth
4.3 APAC Overactive Bladder Treatment Consumption Growth
4.4 Europe Overactive Bladder Treatment Consumption Growth
4.5 Middle East & Africa Overactive Bladder Treatment Consumption Growth

5 AMERICAS

5.1 Americas Overactive Bladder Treatment Consumption by Countries
  5.1.1 Americas Overactive Bladder Treatment Consumption by Countries (2013-2018)
  5.1.2 Americas Overactive Bladder Treatment Value by Countries (2013-2018)
5.2 Americas Overactive Bladder Treatment Consumption by Type
5.3 Americas Overactive Bladder Treatment Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Overactive Bladder Treatment Consumption by Countries
  6.1.1 APAC Overactive Bladder Treatment Consumption by Countries (2013-2018)
  6.1.2 APAC Overactive Bladder Treatment Value by Countries (2013-2018)
6.2 APAC Overactive Bladder Treatment Consumption by Type
6.3 APAC Overactive Bladder Treatment Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 EUROPE

7.1 Europe Overactive Bladder Treatment by Countries
  7.1.1 Europe Overactive Bladder Treatment Consumption by Countries (2013-2018)
  7.1.2 Europe Overactive Bladder Treatment Value by Countries (2013-2018)
7.2 Europe Overactive Bladder Treatment Consumption by Type
7.3 Europe Overactive Bladder Treatment Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Overactive Bladder Treatment by Countries
  8.1.1 Middle East & Africa Overactive Bladder Treatment Consumption by Countries (2013-2018)
  8.1.2 Middle East & Africa Overactive Bladder Treatment Value by Countries (2013-2018)
8.2 Middle East & Africa Overactive Bladder Treatment Consumption by Type
8.3 Middle East & Africa Overactive Bladder Treatment Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers and Impact
  9.1.1 Growing Demand from Key Regions
  9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 MARKETING, DISTRIBUTORS AND CUSTOMER

10.1 Sales Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
10.2 Overactive Bladder Treatment Distributors
10.3 Overactive Bladder Treatment Customer

11 GLOBAL OVERACTIVE BLADDER TREATMENT MARKET FORECAST

11.1 Global Overactive Bladder Treatment Consumption Forecast (2018-2023)
11.2 Global Overactive Bladder Treatment Forecast by Regions
  11.2.1 Global Overactive Bladder Treatment Forecast by Regions (2018-2023)
  11.2.2 Global Overactive Bladder Treatment Value Forecast by Regions (2018-2023)
  11.2.3 Americas Consumption Forecast
  11.2.4 APAC Consumption Forecast
  11.2.5 Europe Consumption Forecast
  11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
  11.3.1 United States Market Forecast
  11.3.2 Canada Market Forecast
  11.3.3 Mexico Market Forecast
  11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
  11.4.1 China Market Forecast
  11.4.2 Japan Market Forecast
  11.4.3 Korea Market Forecast
  11.4.4 Southeast Asia Market Forecast
  11.4.5 India Market Forecast
  11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
  11.5.1 Germany Market Forecast
  11.5.2 France Market Forecast
  11.5.3 UK Market Forecast
  11.5.4 Italy Market Forecast
  11.5.5 Russia Market Forecast
  11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
  11.6.1 Egypt Market Forecast
  11.6.2 South Africa Market Forecast
  11.6.3 Israel Market Forecast
  11.6.4 Turkey Market Forecast
  11.6.5 GCC Countries Market Forecast
11.7 Global Overactive Bladder Treatment Forecast by Type
11.8 Global Overactive Bladder Treatment Forecast by Application

12 KEY PLAYERS ANALYSIS

12.1 Astellas Pharma
  12.1.1 Company Details
  12.1.2 Overactive Bladder Treatment Product Offered
  12.1.3 Astellas Pharma Overactive Bladder Treatment Sales, Revenue, Price and Gross Margin (2016-2018)
  12.1.4 Main Business Overview
  12.1.5 Astellas Pharma News
12.2 Allergan
  12.2.1 Company Details
  12.2.2 Overactive Bladder Treatment Product Offered
  12.2.3 Allergan Overactive Bladder Treatment Sales, Revenue, Price and Gross Margin (2016-2018)
  12.2.4 Main Business Overview
  12.2.5 Allergan News
12.3 Pfizer
  12.3.1 Company Details
  12.3.2 Overactive Bladder Treatment Product Offered
  12.3.3 Pfizer Overactive Bladder Treatment Sales, Revenue, Price and Gross Margin (2016-2018)
  12.3.4 Main Business Overview
  12.3.5 Pfizer News
12.4 Teva (Activas)
  12.4.1 Company Details
  12.4.2 Overactive Bladder Treatment Product Offered
  12.4.3 Teva (Activas) Overactive Bladder Treatment Sales, Revenue, Price and Gross Margin (2016-2018)
  12.4.4 Main Business Overview
  12.4.5 Teva (Activas) News
12.5 Johnson & Johnson
  12.5.1 Company Details
  12.5.2 Overactive Bladder Treatment Product Offered
  12.5.3 Johnson & Johnson Overactive Bladder Treatment Sales, Revenue, Price and Gross Margin (2016-2018)
  12.5.4 Main Business Overview
  12.5.5 Johnson & Johnson News

13 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Overactive Bladder Treatment
Table Product Specifications of Overactive Bladder Treatment
Figure Overactive Bladder Treatment Report Years Considered
Figure Market Research Methodology
Figure Global Overactive Bladder Treatment Consumption Growth Rate 2013-2023 (K Units)
Figure Global Overactive Bladder Treatment Value Growth Rate 2013-2023 ($ Millions)
Table Overactive Bladder Treatment Consumption CAGR by Region 2013-2023 ($ Millions)
Figure Product Picture of Anticholinergics
Table Major Players of Anticholinergics
Figure Product Picture of Mirabegron
Table Major Players of Mirabegron
Figure Product Picture of Botox
Table Major Players of Botox
Table Global Consumption Sales by Type (2013-2018)
Table Global Overactive Bladder Treatment Consumption Market Share by Type (2013-2018)
Figure Global Overactive Bladder Treatment Consumption Market Share by Type (2013-2018)
Table Global Overactive Bladder Treatment Revenue by Type (2013-2018) ($ million)
Table Global Overactive Bladder Treatment Value Market Share by Type (2013-2018) ($ Millions)
Figure Global Overactive Bladder Treatment Value Market Share by Type (2013-2018)
Table Global Overactive Bladder Treatment Sale Price by Type (2013-2018)
Figure Overactive Bladder Treatment Consumed in Idiopathic Overactive Bladder
Figure Global Overactive Bladder Treatment Market: Idiopathic Overactive Bladder (2013-2018) (K Units)
Figure Global Overactive Bladder Treatment Market: Idiopathic Overactive Bladder (2013-2018) ($ Millions)
Figure Global Idiopathic Overactive Bladder YoY Growth ($ Millions)
Figure Overactive Bladder Treatment Consumed in Neurogenic Overactive Bladder
Figure Global Overactive Bladder Treatment Market: Neurogenic Overactive Bladder (2013-2018) (K Units)
Figure Global Overactive Bladder Treatment Market: Neurogenic Overactive Bladder (2013-2018) ($ Millions)
Figure Global Neurogenic Overactive Bladder YoY Growth ($ Millions)
Table Global Consumption Sales by Application (2013-2018)
Table Global Overactive Bladder Treatment Consumption Market Share by Application (2013-2018)
Figure Global Overactive Bladder Treatment Consumption Market Share by Application (2013-2018)
Table Global Overactive Bladder Treatment Value by Application (2013-2018)
Table Global Overactive Bladder Treatment Value Market Share by Application (2013-2018)
Figure Global Overactive Bladder Treatment Value Market Share by Application (2013-2018)
Table Global Overactive Bladder Treatment Sale Price by Application (2013-2018)
Table Global Overactive Bladder Treatment Sales by Players (2016-2018) (K Units)
Table Global Overactive Bladder Treatment Sales Market Share by Players (2016-2018)
Figure Global Overactive Bladder Treatment Sales Market Share by Players in 2016
Figure Global Overactive Bladder Treatment Sales Market Share by Players in 2017
Table Global Overactive Bladder Treatment Revenue by Players (2016-2018) ($ Millions)
Table Global Overactive Bladder Treatment Revenue Market Share by Players (2016-2018)
Figure Global Overactive Bladder Treatment Revenue Market Share by Players in 2016
Figure Global Overactive Bladder Treatment Revenue Market Share by Players in 2017
Table Global Overactive Bladder Treatment Sale Price by Players (2016-2018)
Figure Global Overactive Bladder Treatment Sale Price by Players in 2017
Table Global Overactive Bladder Treatment Manufacturing Base Distribution and Sales Area by Players
Table Players Overactive Bladder Treatment Products Offered
Table Overactive Bladder Treatment Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
Table Global Overactive Bladder Treatment Consumption by Regions 2013-2018 (K Units)
Table Global Overactive Bladder Treatment Consumption Market Share by Regions 2013-2018
Figure Global Overactive Bladder Treatment Consumption Market Share by Regions 2013-2018
Table Global Overactive Bladder Treatment Value by Regions 2013-2018 ($ Millions)
Table Global Overactive Bladder Treatment Value Market Share by Regions 2013-2018
Figure Global Overactive Bladder Treatment Value Market Share by Regions 2013-2018
Figure Americas Overactive Bladder Treatment Consumption 2013-2018 (K Units)
Figure Americas Overactive Bladder Treatment Value 2013-2018 ($ Millions)
Figure APAC Overactive Bladder Treatment Consumption 2013-2018 (K Units)
Figure APAC Overactive Bladder Treatment Value 2013-2018 ($ Millions)
Figure Europe Overactive Bladder Treatment Consumption 2013-2018 (K Units)
Figure Europe Overactive Bladder Treatment Value 2013-2018 ($ Millions)
Figure Middle East & Africa Overactive Bladder Treatment Consumption 2013-2018 (K Units)
Figure Middle East & Africa Overactive Bladder Treatment Value 2013-2018 ($ Millions)
Table Americas Overactive Bladder Treatment Consumption by Countries (2013-2018) (K Units)
Table Americas Overactive Bladder Treatment Consumption Market Share by Countries (2013-2018)
Figure Americas Overactive Bladder Treatment Consumption Market Share by Countries in 2017
Table Americas Overactive Bladder Treatment Value by Countries (2013-2018) ($ Millions)
Table Americas Overactive Bladder Treatment Value Market Share by Countries (2013-2018)
Figure Americas Overactive Bladder Treatment Value Market Share by Countries in 2017
Table Americas Overactive Bladder Treatment Consumption by Type (2013-2018) (K Units)
Table Americas Overactive Bladder Treatment Consumption Market Share by Type (2013-2018)
Figure Americas Overactive Bladder Treatment Consumption Market Share by Type in 2017
Table Americas Overactive Bladder Treatment Consumption by Application (2013-2018) (K Units)
Table Americas Overactive Bladder Treatment Consumption Market Share by Application (2013-2018)
Figure Americas Overactive Bladder Treatment Consumption Market Share by Application in 2017
Figure United States Overactive Bladder Treatment Consumption Growth 2013-2018 (K Units)
Figure United States Overactive Bladder Treatment Value Growth 2013-2018 ($ Millions)
Figure Canada Overactive Bladder Treatment Consumption Growth 2013-2018 (K Units)
Figure Canada Overactive Bladder Treatment Value Growth 2013-2018 ($ Millions)
Figure Mexico Overactive Bladder Treatment Consumption Growth 2013-2018 (K Units)
Figure Mexico Overactive Bladder Treatment Value Growth 2013-2018 ($ Millions)
Table APAC Overactive Bladder Treatment Consumption by Countries (2013-2018) (K Units)
Table APAC Overactive Bladder Treatment Consumption Market Share by Countries (2013-2018)
Figure APAC Overactive Bladder Treatment Consumption Market Share by Countries in 2017
Table APAC Overactive Bladder Treatment Value by Countries (2013-2018) ($ Millions)
Table APAC Overactive Bladder Treatment Value Market Share by Countries (2013-2018)
Figure APAC Overactive Bladder Treatment Value Market Share by Countries in 2017
Table APAC Overactive Bladder Treatment Consumption by Type (2013-2018) (K Units)
Table APAC Overactive Bladder Treatment Consumption Market Share by Type (2013-2018)
Figure APAC Overactive Bladder Treatment Consumption Market Share by Type in 2017
Table APAC Overactive Bladder Treatment Consumption by Application (2013-2018) (K Units)
Table APAC Overactive Bladder Treatment Consumption Market Share by Application (2013-2018)
Figure APAC Overactive Bladder Treatment Consumption Market Share by Application in 2017
Figure China Overactive Bladder Treatment Consumption Growth 2013-2018 (K Units)
Figure China Overactive Bladder Treatment Value Growth 2013-2018 ($ Millions)
Figure Japan Overactive Bladder Treatment Consumption Growth 2013-2018 (K Units)
Figure Japan Overactive Bladder Treatment Value Growth 2013-2018 ($ Millions)
Figure Korea Overactive Bladder Treatment Consumption Growth 2013-2018 (K Units)
Figure Korea Overactive Bladder Treatment Value Growth 2013-2018 ($ Millions)
Figure Southeast Asia Overactive Bladder Treatment Consumption Growth 2013-2018 (K Units)
Figure Southeast Asia Overactive Bladder Treatment Value Growth 2013-2018 ($ Millions)
Figure India Overactive Bladder Treatment Consumption Growth 2013-2018 (K Units)
Figure India Overactive Bladder Treatment Value Growth 2013-2018 ($ Millions)
Figure Australia Overactive Bladder Treatment Consumption Growth 2013-2018 (K Units)
Figure Australia Overactive Bladder Treatment Value Growth 2013-2018 ($ Millions)
Table Europe Overactive Bladder Treatment Consumption by Countries (2013-2018) (K Units)
Table Europe Overactive Bladder Treatment Consumption Market Share by Countries (2013-2018)
Figure Europe Overactive Bladder Treatment Consumption Market Share by Countries in 2017
Table Europe Overactive Bladder Treatment Value by Countries (2013-2018) ($ Millions)
Table Europe Overactive Bladder Treatment Value Market Share by Countries (2013-2018)
Figure Europe Overactive Bladder Treatment Value Market Share by Countries in 2017
Table Europe Overactive Bladder Treatment Consumption by Type (2013-2018) (K Units)
Table Europe Overactive Bladder Treatment Consumption Market Share by Type (2013-2018)
Figure Europe Overactive Bladder Treatment Consumption Market Share by Type in 2017
Table Europe Overactive Bladder Treatment Consumption by Application (2013-2018) (K Units)
Table Europe Overactive Bladder Treatment Consumption Market Share by Application (2013-2018)
Figure Europe Overactive Bladder Treatment Consumption Market Share by Application in 2017
Figure Germany Overactive Bladder Treatment Consumption Growth 2013-2018 (K Units)
Figure Germany Overactive Bladder Treatment Value Growth 2013-2018 ($ Millions)
Figure France Overactive Bladder Treatment Consumption Growth 2013-2018 (K Units)
Figure France Overactive Bladder Treatment Value Growth 2013-2018 ($ Millions)
Figure UK Overactive Bladder Treatment Consumption Growth 2013-2018 (K Units)
Figure UK Overactive Bladder Treatment Value Growth 2013-2018 ($ Millions)
Figure Italy Overactive Bladder Treatment Consumption Growth 2013-2018 (K Units)
Figure Italy Overactive Bladder Treatment Value Growth 2013-2018 ($ Millions)
Figure Russia Overactive Bladder Treatment Consumption Growth 2013-2018 (K Units)
Figure Russia Overactive Bladder Treatment Value Growth 2013-2018 ($ Millions)
Figure Spain Overactive Bladder Treatment Consumption Growth 2013-2018 (K Units)
Figure Spain Overactive Bladder Treatment Value Growth 2013-2018 ($ Millions)
Table Middle East & Africa Overactive Bladder Treatment Consumption by Countries (2013-2018) (K Units)
Table Middle East & Africa Overactive Bladder Treatment Consumption Market Share by Countries (2013-2018)
Figure Middle East & Africa Overactive Bladder Treatment Consumption Market Share by Countries in 2017
Table Middle East & Africa Overactive Bladder Treatment Value by Countries (2013-2018) ($ Millions)
Table Middle East & Africa Overactive Bladder Treatment Value Market Share by Countries (2013-2018)
Figure Middle East & Africa Overactive Bladder Treatment Value Market Share by Countries in 2017
Table Middle East & Africa Overactive Bladder Treatment Consumption by Type (2013-2018) (K Units)
Table Middle East & Africa Overactive Bladder Treatment Consumption Market Share by Type (2013-2018)
Figure Middle East & Africa Overactive Bladder Treatment Consumption Market Share by Type in 2017
Table Middle East & Africa Overactive Bladder Treatment Consumption by Application (2013-2018) (K Units)
Table Middle East & Africa Overactive Bladder Treatment Consumption Market Share by Application (2013-2018)
Figure Middle East & Africa Overactive Bladder Treatment Consumption Market Share by Application in 2017
Figure Egypt Overactive Bladder Treatment Consumption Growth 2013-2018 (K Units)
Figure Egypt Overactive Bladder Treatment Value Growth 2013-2018 ($ Millions)
Figure South Africa Overactive Bladder Treatment Consumption Growth 2013-2018 (K Units)
Figure South Africa Overactive Bladder Treatment Value Growth 2013-2018 ($ Millions)
Figure Israel Overactive Bladder Treatment Consumption Growth 2013-2018 (K Units)
Figure Israel Overactive Bladder Treatment Value Growth 2013-2018 ($ Millions)
Figure Turkey Overactive Bladder Treatment Consumption Growth 2013-2018 (K Units)
Figure Turkey Overactive Bladder Treatment Value Growth 2013-2018 ($ Millions)
Figure GCC Countries Overactive Bladder Treatment Consumption Growth 2013-2018 (K Units)
Figure GCC Countries Overactive Bladder Treatment Value Growth 2013-2018 ($ Millions)
Table Overactive Bladder Treatment Distributors List
Table Overactive Bladder Treatment Customer List
Figure Global Overactive Bladder Treatment Consumption Growth Rate Forecast (2018-2023) (K Units)
Figure Global Overactive Bladder Treatment Value Growth Rate Forecast (2018-2023) ($ Millions)
Table Global Overactive Bladder Treatment Consumption Forecast by Countries (2018-2023) (K Units)
Table Global Overactive Bladder Treatment Consumption Market Forecast by Regions
Table Global Overactive Bladder Treatment Value Forecast by Countries (2018-2023) ($ Millions)
Table Global Overactive Bladder Treatment Value Market Share Forecast by Regions
Figure Americas Overactive Bladder Treatment Consumption 2018-2023 (K Units)
Figure Americas Overactive Bladder Treatment Value 2018-2023 ($ Millions)
Figure APAC Overactive Bladder Treatment Consumption 2018-2023 (K Units)
Figure APAC Overactive Bladder Treatment Value 2018-2023 ($ Millions)
Figure Europe Overactive Bladder Treatment Consumption 2018-2023 (K Units)
Figure Europe Overactive Bladder Treatment Value 2018-2023 ($ Millions)
Figure Middle East & Africa Overactive Bladder Treatment Consumption 2018-2023 (K Units)
Figure Middle East & Africa Overactive Bladder Treatment Value 2018-2023 ($ Millions)
Figure United States Overactive Bladder Treatment Consumption 2018-2023 (K Units)
Figure United States Overactive Bladder Treatment Value 2018-2023 ($ Millions)
Figure Canada Overactive Bladder Treatment Consumption 2018-2023 (K Units)
Figure Canada Overactive Bladder Treatment Value 2018-2023 ($ Millions)
Figure Mexico Overactive Bladder Treatment Consumption 2018-2023 (K Units)
Figure Mexico Overactive Bladder Treatment Value 2018-2023 ($ Millions)
Figure Brazil Overactive Bladder Treatment Consumption 2018-2023 (K Units)
Figure Brazil Overactive Bladder Treatment Value 2018-2023 ($ Millions)
Figure China Overactive Bladder Treatment Consumption 2018-2023 (K Units)
Figure China Overactive Bladder Treatment Value 2018-2023 ($ Millions)
Figure Japan Overactive Bladder Treatment Consumption 2018-2023 (K Units)
Figure Japan Overactive Bladder Treatment Value 2018-2023 ($ Millions)
Figure Korea Overactive Bladder Treatment Consumption 2018-2023 (K Units)
Figure Korea Overactive Bladder Treatment Value 2018-2023 ($ Millions)
Figure Southeast Asia Overactive Bladder Treatment Consumption 2018-2023 (K Units)
Figure Southeast Asia Overactive Bladder Treatment Value 2018-2023 ($ Millions)
Figure India Overactive Bladder Treatment Consumption 2018-2023 (K Units)
Figure India Overactive Bladder Treatment Value 2018-2023 ($ Millions)
Figure Australia Overactive Bladder Treatment Consumption 2018-2023 (K Units)
Figure Australia Overactive Bladder Treatment Value 2018-2023 ($ Millions)
Figure Germany Overactive Bladder Treatment Consumption 2018-2023 (K Units)
Figure Germany Overactive Bladder Treatment Value 2018-2023 ($ Millions)
Figure France Overactive Bladder Treatment Consumption 2018-2023 (K Units)
Figure France Overactive Bladder Treatment Value 2018-2023 ($ Millions)
Figure UK Overactive Bladder Treatment Consumption 2018-2023 (K Units)
Figure UK Overactive Bladder Treatment Value 2018-2023 ($ Millions)
Figure Italy Overactive Bladder Treatment Consumption 2018-2023 (K Units)
Figure Italy Overactive Bladder Treatment Value 2018-2023 ($ Millions)
Figure Russia Overactive Bladder Treatment Consumption 2018-2023 (K Units)
Figure Russia Overactive Bladder Treatment Value 2018-2023 ($ Millions)
Figure Spain Overactive Bladder Treatment Consumption 2018-2023 (K Units)
Figure Spain Overactive Bladder Treatment Value 2018-2023 ($ Millions)
Figure Egypt Overactive Bladder Treatment Consumption 2018-2023 (K Units)
Figure Egypt Overactive Bladder Treatment Value 2018-2023 ($ Millions)
Figure South Africa Overactive Bladder Treatment Consumption 2018-2023 (K Units)
Figure South Africa Overactive Bladder Treatment Value 2018-2023 ($ Millions)
Figure Israel Overactive Bladder Treatment Consumption 2018-2023 (K Units)
Figure Israel Overactive Bladder Treatment Value 2018-2023 ($ Millions)
Figure Turkey Overactive Bladder Treatment Consumption 2018-2023 (K Units)
Figure Turkey Overactive Bladder Treatment Value 2018-2023 ($ Millions)
Figure GCC Countries Overactive Bladder Treatment Consumption 2018-2023 (K Units)
Figure GCC Countries Overactive Bladder Treatment Value 2018-2023 ($ Millions)
Table Global Overactive Bladder Treatment Consumption Forecast by Type (2018-2023) (K Units)
Table Global Overactive Bladder Treatment Consumption Market Share Forecast by Type (2018-2023)
Table Global Overactive Bladder Treatment Value Forecast by Type (2018-2023) ($ Millions)
Table Global Overactive Bladder Treatment Value Market Share Forecast by Type (2018-2023)
Table Global Overactive Bladder Treatment Consumption Forecast by Application (2018-2023) (K Units)
Table Global Overactive Bladder Treatment Consumption Market Share Forecast by Application (2018-2023)
Table Global Overactive Bladder Treatment Value Forecast by Application (2018-2023) ($ Millions)
Table Global Overactive Bladder Treatment Value Market Share Forecast by Application (2018-2023)
Table Astellas Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Astellas Pharma Overactive Bladder Treatment Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Astellas Pharma Overactive Bladder Treatment Market Share (2016-2018)
Table Allergan Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Allergan Overactive Bladder Treatment Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Allergan Overactive Bladder Treatment Market Share (2016-2018)
Table Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pfizer Overactive Bladder Treatment Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Pfizer Overactive Bladder Treatment Market Share (2016-2018)
Table Teva (Activas) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Teva (Activas) Overactive Bladder Treatment Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Teva (Activas) Overactive Bladder Treatment Market Share (2016-2018)
Table Johnson & Johnson Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Johnson & Johnson Overactive Bladder Treatment Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Johnson & Johnson Overactive Bladder Treatment Market Share (2016-2018)